Research and Development

Showing 15 posts of 9596 posts found.

Novo Nordisk image

Diabetes – the battle for control

February 15, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Pharma critical of Obama budget

February 15, 2012 Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform

President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Biogen image

Biogen to pay $563 million for Stromedix

February 15, 2012 Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

Ablynx appoints Dr Andreas Menrad as its new chief scientific officer

February 15, 2012 Business Services, Research and Development, Sales and Marketing Abllynx, Menrad, nanobody

Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

New PV Legislation Implementation Plan by the European Medicines Agency

February 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

Premier Research appoints Sean Russell vice president, Marketing

February 14, 2012 Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell

Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …

Quintiles launches new Asian market service

February 13, 2012 Research and Development Asia, Quintiles, emerging markets

Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …
tim_watts

Oxford BioMedica makes management change

February 10, 2012 Research and Development, Sales and Marketing Oxford BioMedica

Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …

Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team

February 9, 2012 Research and Development

 Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …

European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …
GSK picture

GSK posts strong underlying sales growth

February 8, 2012 Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …
The Gateway to Local Adoption Series

Latest content